On this page you will find clinical guidance and treatment pathways that have been approved by GMMMG or its Subgroups.

The table headings below are active links; click a heading to sort in ascending or descending order.

Document Title Issue Date Review Date Status
National supply shortages of prescribed medication for ADHD 20231123 Nov 2023
HRT Guidance for Menopause Management 20230323 Mar 2023 20251223 Dec 2025
Hypersalivation and Sialorrhoea in Adult Patients 20230123 Jan 2023 20251223 Dec 2025
Inappropriate Polypharmacy Review and Treatment Optimisation: Resource Pack 20230223 Feb 2023 20241223 Dec 2024
Tobacco Dependency Treatment Guideline 20220223 Feb 2022 20250123 Jan 2025

Antimicrobial guidelines

Antimicrobial Guidelines 20240123 Jan 2024 20240323 Mar 2024 This guideline is reviewed quarterly; comments will be accepted continuously
Guidelines on the management of outbreaks of influenza-like illness (ILI) in care homes 20201123 Nov 2020 External link to PHE guidance
Long-Term Azithromycin in Adults with Chronic Respiratory Disease: Guidance for Primary Care 20231123 Nov 2023 20260923 Sep 2026

Respiratory

COPD Management Plan 20211123 Nov 2021 Luforbec MDI now replaces Fostair MDI in the COPD management plan. This will be amended within the plan when it is next updated
COPD - Inhaler guide 20230323 Mar 2023
Asthma Management Plan 20220423 Apr 2022 20250423 Apr 2025 Luforbec MDI now replaces Fostair MDI in the asthma management plan. This will be amended within the plan when it is next updated (currently underway)
Asthma Management Plan - Inhaler Guide 20221023 Oct 2022 20250423 Apr 2025
Greener inhaler poster for patients 20220823 Aug 2022 20250423 Apr 2025
Greener inhaler poster for staff 20220823 Aug 2022 20250423 Apr 2025

Cardiovascular

Hypertension medication pathway 20230923 Sep 2023 20260723 Jul 2026
GM Adult Hypertension medication overview table 20230723 Jul 2023 20260723 Jul 2026
GM Adult Hypertension pathway supporting information 20230923 Sep 2023 20260723 Jul 2026
Lipid management pathway (secondary prevention) 20230223 Feb 2023 20250223 Feb 2025 If prescribing inclisiran, please also click here for prescribing, ordering, and cost information.
Additional patient information is also available here.

Diabetes and endocrinology

Managing GLP1 receptor agonist shortages in adults with type 2 diabetes 20240323 Mar 2024
Tirzepatide for Type 2 Diabetes 20240323 Mar 2024 20270323 Mar 2027
The Royal College of Psychiatrists' Oct 2013: Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria 20131023 Oct 2013 RCPsych state that a review of this publication is planned and will take place in due course

CNS and pain

Benzodiazepine and Z-drug prescribing: Resource Pack 20210523 May 2021 20240523 May 2024
Benzodiazepine and Z-drug resource pack: editable appendices 20230423 Apr 2023 20240523 May 2024
Gabapentinoids - Prescribing for pain resource pack 20210623 Jun 2021 20240623 Jun 2024
Gabapentinoids - Prescribing for pain resource pack - PILs and editable resources 20210623 Jun 2021 20240623 Jun 2024
Headache Pathway 20220623 Jun 2022 20250623 Jun 2025
Opioid Resource pack 20231223 Dec 2023 20261223 Dec 2026
Neuropathic Pain in Adults - Guideline for Primary Care 20220523 May 2022 20250523 May 2025
Pain Management Resources Hub External link

High cost drug pathways

High Cost Drug Pathway for Axial Spondyloarthritis in Adults 20230623 Jun 2023 20250223 Feb 2025
High Cost Drug Pathways for Inflammatory Bowel Disease in Adults 20231123 Nov 2023 20251123 Nov 2025
High Cost Drug Pathway for Psoriatic Arthritis in Adults 20230623 Jun 2023 20250223 Feb 2025
High Cost Drugs Pathway for Rheumatoid Arthritis in Adults 20230623 Jun 2023 20250223 Feb 2025

Ophthalmology

High-Cost Drugs Commissioning Pathway for Wet Age-related Macular Degeneration in Adults 20240123 Jan 2024 20251223 Dec 2025 An FAQ document is also in development
Wet AMD treatment pathway 20240123 Jan 2024 20251223 Dec 2025